Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSThree Regulatory News (STEM)

Share Price Information for SThree (STEM)

Share Price is delayed by 15 minutes
Get Live Data
170.20    -0.20 (-0.12%)
Bid:
170.20
Ask:
170.80
Spread: 0.60 (0.353%)
Market Cap: £208.86m
STEM Live PriceLast checked at - London Stock Exchange

Intraday SThree Share Chart

SThree: Director Declaration

27 Sep 2021 09:41

SThree (STEM) SThree: Director Declaration 27-Sep-2021 / 09:40 GMT/BST Dissemination of a Regulatory Announcement, transmitted by EQS Group. The issuer is solely responsible for the content of this announcement.


 

27 September 2021

 

SThree plc

 

(the "Company")

 

 

 

Director Declaration

SThree plc announces that its senior independent non-executive director, Denise Collis, has been appointed as a non-executive director of EMIS Group plc ("EMIS") and will join the board of EMIS on 1 October 2021. Denise will be Chair of their remuneration committee and be a member of their audit and nomination committees.

This notification is made pursuant to Listing Rule 9.6.14(2) of the Listing Rules of the Financial Conduct Authority.

 

 

 

Bill Warner

Deputy Company Secretary

 

 

 

 

 

 


ISIN:GB00B0KM9T71
Category Code:MSCL
TIDM:STEM
LEI Code:2138003NEBX5VRP3EX50
OAM Categories: 3.1. Additional regulated information required to be disclosed under the laws of a Member State
Sequence No.:122972
EQS News ID:1236078
 
End of AnnouncementEQS News Service

UK Regulatory announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
2nd Sep 20242:30 pmRNSChange of Registered Office
2nd Sep 202410:51 amRNSTotal Voting Rights
23rd Aug 202411:00 amRNSBlock listing Interim Review
12th Aug 20242:00 pmRNSDirector/PDMR Shareholding
1st Aug 202411:30 amRNSTotal Voting Rights
23rd Jul 20245:31 pmRNSDirector/PDMR Shareholding
23rd Jul 20247:01 amRNSNotice of Investor Briefing
23rd Jul 20247:00 amRNSFY24 Half Year Results
16th Jul 20247:00 amRNSNotice of Third Investor Briefing
12th Jul 20243:30 pmRNSDirector/PDMR Shareholding
1st Jul 202411:42 amRNSTotal Voting Rights
18th Jun 20247:00 amRNSFY24 Half Year Trading Update
13th Jun 20241:26 pmRNSDirector/PDMR Shareholding
11th Jun 20242:35 pmRNSDirector/PDMR Shareholding
3rd Jun 20249:50 amRNSTotal Voting Rights
13th May 20244:00 pmRNSDirector/PDMR Shareholding
25th Apr 202411:44 amRNSResult of AGM
15th Apr 20243:48 pmRNSDirector/PDMR Shareholding
10th Apr 202412:14 pmRNSChange of Auditor
2nd Apr 202412:10 pmRNSDirectorate Change
22nd Mar 20244:29 pmRNSDirector/PDMR Shareholding
19th Mar 20243:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFY24 Q1 Trading Update
14th Mar 202412:11 pmRNSDirector/PDMR Shareholding
12th Mar 20243:59 pmRNSDirector/PDMR Shareholding
7th Mar 20249:20 amRNSDirector/PDMR Shareholding
4th Mar 202410:54 amRNSAnnual Financial Report
23rd Feb 20242:00 pmRNSBlock listing Interim Review
13th Feb 20244:45 pmRNSDirector/PDMR Shareholding
1st Feb 202410:20 amRNSTotal Voting Rights
30th Jan 20247:00 amRNSFY23 Final Results
23rd Jan 20244:25 pmRNSChange of Registrar
15th Jan 20241:19 pmRNSDirector/PDMR Shareholding
18th Dec 20234:56 pmRNSDirector/PDMR Shareholding
14th Dec 202310:58 amRNSDirector/PDMR Shareholding
14th Dec 20237:00 amRNSFY23 Full Year Trading Update
8th Dec 20234:30 pmRNSDirectorate Change
1st Dec 20232:27 pmRNSTotal Voting Rights
23rd Nov 20237:00 amRNSAppointment of Joint Corporate Brokers
16th Nov 202312:41 pmRNSDirector/PDMR Shareholding
14th Nov 20239:45 amRNSHolding(s) in Company
2nd Nov 20232:45 pmRNSTotal Voting Rights
16th Oct 20232:02 pmRNSDirector/PDMR Shareholding
2nd Oct 20233:53 pmRNSTotal Voting Rights
20th Sep 20231:19 pmRNSDirector/PDMR Shareholding
19th Sep 20237:00 amRNSFY23 Q3 Trading Update
13th Sep 202310:35 amRNSDirector/PDMR Shareholding
1st Sep 202312:17 pmRNSTotal Voting Rights
23rd Aug 202311:40 amRNSBlock listing Interim Review
16th Aug 20232:16 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.